Evidence map›Paper›PMID 26609132›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2015

Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward.

Ruth A Roberts, Michael Aschner, David Calligaro, Tomas R Guilarte, Joseph P Hanig, David W Herr, Thomas J Hudzik, Andreas Jeromin, Mary J Kallman, Serguei Liachenko and 6 more

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Enteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?Comprehensive reviews in food science and food safety · 2026
    Pooled it
  2. Review
  3. Isolation and Characterization of Cell-Free DNA from Cerebral Organoids.International journal of molecular sciences · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Profiling Secreted miRNA Biomarkers of Chemical-Induced Neurodegeneration in Human iPSC-Derived Neurons.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration.Experimental biology and medicine (Maywood, N.J.) · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ruth A Roberts*ApconiX, BioHub at Alderley Park, Cheshire SK10 4TG, UK; ruth.roberts@apconix.com.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461;
David CalligaroEli Lilly & Co., Pharmacology/Toxicology Research Lilly Research Labs, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285;
Tomas R Guilarte§Columbia University, New York, New York 10032;
Joseph P HanigU.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland 20993;
David W HerrUS EPA, Toxicology Assessment Division, NHEERL, Research Triangle Park, North Carolona 27711;
Thomas J HudzikAbbVie, Inc., North Chicago, Illinois 60064;
Andreas JerominQuanterix, Inc., Lexington, Massachusetts 02421;
Mary J KallmanCovance, Inc., 8211 SciCor Drive, Indianapolis, Indiana 46214;
Serguei Liachenko**U.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas 72079;
James J LynchQuanterix, Inc., Lexington, Massachusetts 02421;
Diane B MillerCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505; and.
Virginia C MoserUS EPA, Toxicology Assessment Division, NHEERL, Research Triangle Park, North Carolona 27711;
James P O'CallaghanCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505; and.
William Slikker**U.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas 72079;
Merle G PauleCenters for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505; and.

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
NIEHS NIH HHS P30 ES009089
6 · The paper itself

Abstract

Neurotoxicity has been linked to a number of common drugs and chemicals, yet efficient and accurate methods to detect it are lacking. There is a need for more sensitive and specific biomarkers of neurotoxicity that can help diagnose and predict neurotoxicity that are relevant across animal models and translational from nonclinical to clinical data. Fluid-based biomarkers such as those found in serum, plasma, urine, and cerebrospinal fluid (CSF) have great potential due to the relative ease of sampling compared with tissues. Increasing evidence supports the potential utility of fluid-based biomarkers of neurotoxicity such as microRNAs, F2-isoprostanes, translocator protein, glial fibrillary acidic protein, ubiquitin C-terminal hydrolase L1, myelin basic protein, microtubule-associated protein-2, and total tau. However, some of these biomarkers such as those in CSF require invasive sampling or are specific to one disease such as Alzheimer's, while others require further validation. Additionally, neuroimaging methodologies, including magnetic resonance imaging, magnetic resonance spectroscopy, and positron emission tomography, may also serve as potential biomarkers and have several advantages including being minimally invasive. The development of biomarkers of neurotoxicity is a goal shared by scientists across academia, government, and industry and is an ideal topic to be addressed via the Health and Environmental Sciences Institute (HESI) framework which provides a forum to collaborate on key challenging scientific topics. Here we utilize the HESI framework to propose a consensus on the relative potential of currently described biomarkers of neurotoxicity to assess utility of the selected biomarkers using a nonclinical model.

Indexed as

AnimalsBiomarkersDisease Models, AnimalGenetic MarkersHumansNervous SystemNeurotoxicity SyndromesPredictive Value of TestsPrognosisReproducibility of ResultsRisk AssessmentToxicologyTranslational Research, BiomedicalBiomarkersGenetic MarkersbiomarkerCSFimagingneurotoxicity

Identifiers

PMID26609132
PMCPMC4659531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.